List of substances prohibited for circulation in the Russian Federation. Narcotic psychotropic drugs and substances: complete list. List of psychotropic and narcotic drugs and substances

LIST OF NARCOTIC DRUGS, PSYCHOTROPIC SUBSTANCES SUBJECT TO CONTROLIN RUSSIAN FEDERATION

(according to Government Decree No. 681 of June 30, 1998, as amended to enter into force on January 1, 2013)

The circulation of these substances in Russia is prohibited under threat of punishment.

List of narcotic drugs,

psychotropic substances, the circulation of which

prohibited in the Russian Federation according to

with the legislation of the Russian Federation and international

treaties of the Russian Federation (list I)

(as amended by Decree of the Government of the Russian Federation dated November 23, 2012 N 1215)

Narcotic drugs

N-(adamantan-1-yl)-1-pentyl-1H-indazol-3-carboxamide and its derivatives, with the exception of derivatives included as independent items in the list (introduced by Decree of the Government of the Russian Federation of November 23, 2012 N 1215)

N-(adamantan-1-yl)-1-pentyl-1H-indole-3-carboxamide and its derivatives, with the exception of derivatives included as independent items in the list (introduced by Decree of the Government of the Russian Federation of November 23, 2012 N 1215)

3-Adamantoylindole [(Adamantan-1-yl)(1H-indol-3-yl)methanone] and its derivatives, with the exception of derivatives included as independent items in the list

Allylprodine

Alfameprodine

Alfamethadol

Alpha methylfentanyl

Alpha methylthiofentanyl

Alfaprodine

Alphacetylmethadol

2-Amino-1-benzodifuran-4-ylethan and its derivatives, with the exception of derivatives included as independent items in the list (introduced by Decree of the Government of the Russian Federation of October 6, 2011 N 822)

2-Aminoindan and its derivatives, with the exception of derivatives included as independent items in the list (introduced by Decree of the Government of the Russian Federation of October 6, 2011 N 822)

AMT (alpha-methyltryptamine) and its derivatives, with the exception of derivatives included as independent items in the list (introduced by Decree of the Government of the Russian Federation of May 18, 2012 N 491)

Anileridine

Acetyl-alphamethylfentanyl

Acetyldihydrocodeine

Acetylated opium

Acetylcodeine

Acetylmethadol

Acetyl fentanyl (introduced by Decree of the Government of the Russian Federation of November 23, 2012 N 1215)

7-Acetoxymitragynine (introduced by Decree of the Government of the Russian Federation of October 6, 2011 N 822)

Acetorphine

BDB

Bezitramide

Benzetidine

Benzylmorphine

3-Benzoylindole [(1H-indol-3-yl)phenylmethanone] and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated October 6, 2011 N 822)

Beta-hydroxy-3-methylfentanyl

Beta-hydroxyfentanyl

Betameprodine

Betamethadol

Betaprodine

Betacetylmethadol

Brolamphetamine (DOB, d, L-4-bromo-2,5-dimethoxy-alpha-methyl-phenethylamine)

3-Butanoyl-1-methylindole and its derivatives, with the exception of derivatives included as independent items in the list

3-Butanoyl-1-methylindole and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated February 22, 2012 N 144)

(1-Butyl-1H-indol-3-yl)(naphthalene-1-yl)methanone ( -073) and its derivatives, with the exception of derivatives included as independent items in the list

Hydrocodone

4-Hydroxytryptamine and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated October 6, 2011 N 822)

5-Hydroxy-N-methyltryptamine and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated October 6, 2011 N 822)

N-hydroxy-MDA

7-Hydroxymitragynine

(introduced by Decree of the Government of the Russian Federation dated October 6, 2011 N 822)

Hydroxypetidine

2-[(1R,3S)-3-Hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol (CP 47.497) and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation dated October 30, 2010 N 882)

2-[(1R,3S)-3-Hydroxycyclohexyl]-5-(2-methylheptan-2-yl)phenol (CP 47.497)-C6) and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation dated October 30, 2010 N 882)

2-[(1R,3S)-3-Hydroxycyclohexyl]-5-(2-methyldecan-2-yl)phenol (CP 47.497)-C9) and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation dated October 30, 2010 N 882)

2-[(1R,3S)-3-Hydroxycyclohexyl]-5-(2-methylnonan-2-yl)phenol (CP 47.497)-C8) and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation dated October 30, 2010 N 882)

Hydromorphinol

6-deoxycodeine

The position is excluded. — Decree of the Government of the Russian Federation dated March 11, 2011 N 158

Desomorphine

Dihydromorphine

Dimenoxadol

N-Dimethylamphetamine

Dimethocaine [(3-diethylamino-2,2-dimethylpropyl)-4-aminobenzoate]

(introduced by Decree of the Government of the Russian Federation dated February 22, 2012 N 144)

2,5-Dimethoxyphenethylamine and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated October 6, 2011 N 822)

Dimepheptanol

Dimethylthiambutene

(6aR, 10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a, 7, 10, 10a-tetrahydrobenzo[c]chromen-1-ol (HU- 210) and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation dated October 30, 2010 N 882)

2C-T-7 (2,5-dimethoxy-4-N-propylthiophenethylamine)

(introduced by Decree of the Government of the Russian Federation dated 07/08/2006 N 421)

Dioxafetyl butyrate

Dipipanon

Difenoxin

Diethylthiambutene

DMA (d, L-2,5-dimethoxy-alpha-methyl-phenyl-ethylamine)

DMHP (dimethylheptylpyran)

DMT (dimethyltryptamine) and its derivatives, with the exception of derivatives included as independent items in the list

(as amended by Decree of the Government of the Russian Federation dated October 6, 2011 N 822)

The position is excluded. — Decree of the Government of the Russian Federation of June 30, 2010 N 486

DOX (d, L-2,5-dimethoxy-4-chloroamphetamine)

DOET (d, L-2,5-dimethoxy-4-ethyl-amphetamine)

Drotebanol

DET (N,N-diethyltryptamine)

Ketobemidon

Clonitazene

Kodoxim

The position is excluded. — Decree of the Government of the Russian Federation of November 27, 2010 N 934

Homemade preparations from ephedrine (pseudoephedrine) or from preparations containing ephedrine (pseudoephedrine) (as amended by Decree of the Government of the Russian Federation dated March 3, 2012 N 169)

The position is excluded. — Decree of the Government of the Russian Federation dated March 3, 2012 N 169

Homemade preparations from phenylpropanolamine or from preparations containing phenylpropanolamine (introduced by Decree of the Government of the Russian Federation of July 8, 2006 N 421)

Levomethorphan

Levomoramide

Levorphanol (Lemoran)

Levophenacylmorphan

The position was eliminated as of January 1, 2013. — Decree of the Government of the Russian Federation dated October 1, 2012 N 1003

The position is excluded. — Decree of the Government of the Russian Federation of November 27, 2010 N 934

MBDB

MDA (tenamphetamine)

MDMA (d, L-3,4-methylenedioxy-N-alpha-dimethyl-phenyl-ethylamine)

3-Monoacetylmorphine

6-Monoacetylmorphine

Mescaline

Methadone (phenadone, dolophine)

(as amended by Decree of the Government of the Russian Federation dated June 30, 2010 N 486)

The position is excluded. — Decree of the Government of the Russian Federation of June 30, 2010 N 486

The position is excluded. — Decree of the Government of the Russian Federation of June 30, 2010 N 486

Methadone intermediate (4-cyano-2-dimethylamino-4,4-diphenylbutane)

Metazocin

Methamphetamine (Pervitin)

(as amended by Decree of the Government of the Russian Federation dated June 30, 2010 N 486)

Methyldesorphin

Methyldihydromorphine

Methylenedioxypyrovalerone (introduced by Decree of the Government of the Russian Federation of February 25, 2011 N 112)

6-methyl-2-[(4-methylphenyl)amino]-4H-3,1-benzoxazin-4-one

(introduced by Decree of the Government of the Russian Federation dated November 23, 2012 N 1215)

Methylone (3,4-methylenedioxy-N-methylcathinone)

2-Methyl-1-pentyl-1H-indol-3-yl-(1-naphthyl)methane (JWH-196) and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation dated October 30, 2010 N 882)

2-Methyl-1-pentyl-1H-indol-3-yl-(4-methyl-1-naphthyl)methane (JWH-194) and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation dated October 30, 2010 N 882)

2-Methyl-1-pentyl-1H-indol-3-yl-(4-methoxy-1-naphthyl)methane (JWH-197) and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation dated October 30, 2010 N 882)

(2-Methyl-1-pentyl-1H-indol-3-yl)(naphthalene-1-yl)methanone (JWH-007) and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation dated October 30, 2010 N 882)

(4-Methylnaphthalene-1-yl)(2-methyl-1-pentyl-1H-indo-3-yl)methanone (JWH-149) and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation dated October 30, 2010 N 882)

(2-Methyl-1-pentyl-1H-indol-3-yl)(4-methoxynaphthalen-1-yl)methanone (JWH-098) and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation dated October 30, 2010 N 882)

3-methylthiofentanyl

3-methylfentanyl

N-methylephedrone and its derivatives, with the exception of derivatives included as independent items in the list

Methoxetamine and its derivatives, with the exception of derivatives included as independent items in the list (introduced by Decree of the Government of the Russian Federation of October 6, 2011 N 822)

N--2,2,3,3-tetramethylcyclopropane-1-carboxamide (introduced by Decree of the Government of the Russian Federation of November 23, 2012 N 1215)

Mephedrone (4-methylmethcathinone)

(introduced by Decree of the Government of the Russian Federation dated July 29, 2010 N 578)

Mitragynine (9-methoxy-corynantheidine) and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated October 6, 2011 N 822)

The milky juice of different types of poppy, which are not poppy somniferous (plant of the species Papaver somniferum L), but containing poppy alkaloids included in the lists of narcotic drugs and psychotropic substances

MMDA (2-methoxy-alpha-4-methyl 4,5-(methylenedioxy)-phenethylamine)

Moramide, intermediate (2-methyl-3-morpholine-1, 1-diphenylpropane-carboxylic acid)

Morpheridine

Morphine methyl bromide

Morphine-N-oxide

JWH-195) and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation dated October 30, 2010 N 882)

(4-Methylnaphthalene-1-yl)(1--1H-indol-3-yl)methane (JWH-192) and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation dated October 30, 2010 N 882)

(4-Methoxy-1-naphthyl)(1--1H-indol-3-yl)methane (JWH-199) and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation dated October 30, 2010 N 882)

(1--1H-indol-3-yl)(naphthalene-1-yl)methanone (JWH-200) and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation dated October 30, 2010 N 882)

(4-Methylnaphthalene-1-yl)(1--1H-indol-3-yl)methanone (JWH-193) and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation dated October 30, 2010 N 882)

(4-Methoxy-1-naphthyl)(1--1H-indol-3-yl)methanone (JWH-198) and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation dated October 30, 2010 N 882)

MPPP (MPPP (1-methyl-4-phenyl-4-piperidinol propionate (ester))

(as amended by Decree of the Government of the Russian Federation dated June 30, 2010 N 486)

(E)-1-pentane (JWH-176) and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation dated October 30, 2010 N 882)

(Naphthalene-1-yl)(1H-pyrrol-3-yl)methanone and its derivatives, with the exception of derivatives included as independent items in the list (introduced by Decree of the Government of the Russian Federation of October 6, 2011 N 822)

(Naphthalene-1-yl)(4-pentyloxynaphthalene-1-yl)methanone and its derivatives, with the exception of derivatives included as independent items in the list (introduced by Decree of the Government of the Russian Federation of May 18, 2012 N 491)

3-Naphthoylindole [(1H-indol-3-yl)(naphthalene-1-yl)methanone] and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated October 6, 2011 N 822)

Nikodikodin

Nicocodin

Nicomorphine

Noracimethadol

Norcodeine

Norlevorphanol

Normethadone

Normorphine

Norpipanon

Oxymorphone

- coagulated juice of the poppy somniferum (plant of the species Papaver somniferum L)

(as amended by Decree of the Government of the Russian Federation dated November 27, 2010 N 934)

The position is excluded. — Decree of the Government of the Russian Federation of November 27, 2010 N 934

Oripavin

Para-fluorofentanyl (para-fluorofentanyl)

Parahexyl

(4-Methylnaphthalene-1-yl)(1-pentyl-1H-indol-3-yl)methanone (JWH-122) and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation dated October 30, 2010 N 882)

(4-Methoxynaphthalene-1-yl)(1-pentyl-1H-indol-3-yl)methanone (JWH-081) and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation dated October 30, 2010 N 882)

(Naphthalene-1-yl)(1-pentyl-1H-indol-3-yl)methanone (JWH-018) and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation dated October 30, 2010 N 882)

1-Pentyl-1H-indol-3-yl-(1-naphthyl)methane (JWH-175) and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation dated October 30, 2010 N 882)

1-Pentyl-1H-indol-3-yl-(4-methyl-1-naphthyl)methane (JWH-184) and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation dated October 30, 2010 N 882)

1-Pentyl-1H-indol-3-yl-(4-methoxy-1-naphthyl)methane (JWH-185) and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation dated October 30, 2010 N 882)

PEPAP (L-phenethyl-4-phenyl-4-piperidinol acetate (ester))

Pethidine Intermediate A (4-cyano-1-methyl-4-phenylpiperidine)

Pethidine Intermediate B (4-phenylpiperidine-4-carboxylic acid ethyl ester)

(introduced by Decree of the Government of the Russian Federation dated 07/08/2006 N 421)

Pethidine, intermediate C (1-methyl-4-phenylpiperidine-4-carboxylic acid)

(introduced by Decree of the Government of the Russian Federation dated 07/08/2006 N 421)

Piminodine

(Piperidin-2-yl)diphenylmethane and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated October 6, 2011 N 822)

(Pyrrolidin-2-yl)diphenylmethane and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated October 6, 2011 N 822)

The position is excluded. — Decree of the Government of the Russian Federation of November 27, 2010 N 934

PMA (4-methoxy-alpha-methylphenyl-ethylamine)

Proheptazine

The position is excluded. — Decree of the Government of the Russian Federation dated 07/08/2006 N 421

The position is excluded. — Decree of the Government of the Russian Federation dated 07/08/2006 N 421

Psilocybin

Psilocin

Racemethorphan

Racemoramide

Racemorphan

Rolicyclidine

Salvinorin A

(introduced by Decree of the Government of the Russian Federation dated December 31, 2009 N 1186)

2C-B (4-bromo-2,5-dimethoxyphenethylamine)

STP (DOM)

The position is excluded. — Decree of the Government of the Russian Federation of November 27, 2010 N 934

Tebacon (acetyldihydrocodeinone)

(as amended by Decree of the Government of the Russian Federation dated June 30, 2010 N 486)

Tenocyclidine (TCP)

(as amended by Decree of the Government of the Russian Federation dated June 30, 2010 N 486)

(all isomers)

2-Thiophen-2-ylethylamine and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated October 6, 2011 N 822)

Thiofentanil

TMA (d, L-3,4,5-trimethoxy-alpha-methylphenyl-amine)

TFMPP (1-(3-trifluoromethylphenyl)piperazine)

(introduced by Decree of the Government of the Russian Federation dated 07/08/2006 N 421)

Phenadoxone

The position is excluded. — Decree of the Government of the Russian Federation of June 30, 2010 N 486

Phenazocine

Fenampromide

1-Phenylpiperazine and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated October 6, 2011 N 822)

1-Phenylcyclohexylamine and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated October 6, 2011 N 822)

Phenylacetylindole and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated July 7, 2011 N 540)

Phencyclidine

Phenomorphan

Phenoperidine

Fenfluramine

(introduced by Decree of the Government of the Russian Federation dated 07/08/2006 N 421)

Folkodin

Furetidine

Chlorophenylpiperazine

(introduced by Decree of the Government of the Russian Federation dated June 30, 2010 N 486)

The position is excluded. — Decree of the Government of the Russian Federation of November 27, 2010 N 934

Ecgonine, its esters and derivatives, which can be converted to ecgonine and cocaine

Poppy straw extract (poppy straw concentrate)

N-ETHYL-MDA (d, L-N-ethyl-alpha-methyl-3,4-(methylenedioxy) - phenethylamyl)

Ethylmethylthiambutene

1-Ethyl-1-pentyl-3-(1-naphthoyl)indole (JWH-116) and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated December 31, 2009 N 1186, as amended by Decree of the Government of the Russian Federation dated October 30, 2010 N 882)

Ethycyclidine

Ethoxyridine

Etonitazene

Etryptamine

Ephedrone (methcathinone) and its derivatives, with the exception of derivatives included as independent items in the list

(as amended by Decree of the Government of the Russian Federation dated October 30, 2010 N 882)

Psychotropic substances

Amphetamine and its derivatives, with the exception of derivatives included as independent items in the list

(as amended by Resolutions of the Government of the Russian Federation dated June 30, 2010 N 486, dated July 7, 2011 N 540)

Cathene (d-norpseudoephedrine)

Cathinone (L-alpha-aminopropiophenone) and its derivatives, with the exception of derivatives included as independent items in the list

(as amended by Decree of the Government of the Russian Federation dated October 30, 2010 N 882)

The position is excluded. — Decree of the Government of the Russian Federation dated 07/08/2006 N 421

Meclocqualone

Methaqualone

4-methylaminorex

Methylphenidate (Ritalin)

Phenethylline

(introduced by Decree of the Government of the Russian Federation dated June 30, 2010 N 486)

1-Phenyl-2-propanone (introduced by Decree of the Government of the Russian Federation of April 21, 2010 N 255)

Isomers, including stereoisomers (unless specifically excluded), of narcotic drugs and psychotropic substances listed in this list, in cases where the existence of such isomers, including stereoisomers, is possible within the framework of this chemical designation

(as amended by Decree of the Government of the Russian Federation dated 07/08/2006 N 421)

Esters and ethers of narcotic drugs and psychotropic substances listed in this list

All mixtures containing narcotic drugs and psychotropic substances on this list, regardless of their quantity

List of narcotic drugs

and psychotropic substances, the circulation of which

which establish control measures in accordance

with the legislation of the Russian Federation

and international treaties of the Russian

Federation (list II)

Narcotic drugs

p-Aminopropiophenone (PAPP) and its optical isomers (antidote against cyanide)

Alfentanil

The position is excluded. — Decree of the Government of the Russian Federation of June 30, 2010 N 486

BZP (N-benzylpiperazine) and its derivatives, with the exception of derivatives included as independent items in the list

(introduced by Decree of the Government of the Russian Federation dated July 8, 2006 N 421, as amended by Decree of the Government of the Russian Federation dated October 6, 2011 N 822)

Buprenorphine

Hydromorphone

(introduced by Decree of the Government of the Russian Federation dated March 11, 2011 N 158)

Glutetimide (Noxiron)

Dextromoramide

Dextropropoxyphene (ibuproxiron, proxivon, spasmoproxivon)

Dihydrocodeine

Dihydroetorphine

(introduced by Decree of the Government of the Russian Federation dated 07/08/2006 N 421)

Diphenoxylate

(introduced by Decree of the Government of the Russian Federation dated 07/08/2006 N 421)

The position is excluded. — Decree of the Government of the Russian Federation of June 30, 2010 N 486

The position is excluded. — Decree of the Government of the Russian Federation of June 30, 2010 N 486

Codeine N-oxide

4-MTA (alpha-methyl-4-methylthiophenethylamine)

(introduced by Decree of the Government of the Russian Federation dated 07/08/2006 N 421)

The position is excluded. — Decree of the Government of the Russian Federation of June 30, 2010 N 486

The position is excluded. — Decree of the Government of the Russian Federation of June 30, 2010 N 486

Morphilong

Oxycodone (tecodin)

(introduced by Decree of the Government of the Russian Federation dated 07/08/2006 N 421)

Pentazocine

Properidine

Propiram

Prosidol

Piritramide (dipidolor)

The position is excluded. — Decree of the Government of the Russian Federation of June 30, 2010 N 486

Remifentanil

(introduced by Decree of the Government of the Russian Federation dated 07/08/2006 N 421)

The position is excluded. — Decree of the Government of the Russian Federation of June 30, 2010 N 486

Sombrevin

Sufentanil

Alnagon tablets (codeine phosphate 20 mg, caffeine 80 mg, phenobarbital 20 mg, acetylsalicylic acid 20 mg)

Tablets (codeine camphosulfonate 0.025 g, potassium sulfaguaiacol 0.100 g, thick grindelia extract 0.017 g)

Codeine tablets 0.03 g + paracetamol 0.500 g

Codeine phosphate tablets 0.015 g + sugar 0.25 g

Codeine tablets 0.01 g, 0.015 g + sugar 0.25 g

Codeine tablets 0.015 g + sodium bicarbonate 0.25 g

Tablets "Codterpine" (codeine 0.015 g + sodium bicarbonate 0.25 g + terpinhydrate 0.25 g)

Cough tablets. Ingredients: thermopsis herb powder - 0.01 g (0.02 g), codeine - 0.02 g (0.01 g), sodium bicarbonate - 0.2 g, licorice root powder - 0.2 g

Trimeperidine (Promedol)

Fentanyl

Ethylmorphine

The position is excluded. — Decree of the Government of the Russian Federation dated 07/08/2006 N 421

The position is excluded. — Decree of the Government of the Russian Federation dated 07/08/2006 N 421

The position is excluded. — Decree of the Government of the Russian Federation of June 30, 2010 N 486

Psychotropic substances

Amobarbital (barbamyl)

Amfepramone (fepranon, diethylpropion) and its derivatives, with the exception of derivatives included as independent items in the list

(as amended by Decree of the Government of the Russian Federation dated October 30, 2010 N 882)

The position is excluded. — Decree of the Government of the Russian Federation of June 30, 2010 N 486

The position is excluded. — Decree of the Government of the Russian Federation of June 30, 2010 N 486

The position is excluded. — Decree of the Government of the Russian Federation of June 30, 2010 N 486

Phenmetrazine

Phentermine

Sodium etaminal (pentobarbital)

(as amended by Decree of the Government of the Russian Federation dated June 30, 2010 N 486)

Halcion (triazolam)

Isomers (unless specifically excluded) of narcotic drugs and psychotropic substances listed in this list, in cases where the existence of such isomers is possible within the framework of this chemical designation

(introduced by Decree of the Government of the Russian Federation dated 07/08/2006 N 421)

Stereoisomers (unless specifically excluded) of narcotic drugs and psychotropic substances listed in this list, in cases where the existence of such stereoisomers is possible within the framework of this chemical designation

(introduced by Decree of the Government of the Russian Federation dated 07/08/2006 N 421)

Salts of all narcotic drugs and psychotropic substances listed in this list, if the existence of such salts is possible

List of psychotropic substances, whose turnover

in the Russian Federation is limited in relation to

which may exclude certain measures

control in accordance with the law

Russian Federation and international treaties

Russian Federation (list III)

(as amended by Decree of the Government of the Russian Federation dated July 4, 2007 N 427)

Allobarbital

Amineptine

Aminorex

Benzphetamine

Butalbital

Butobarbital

Butorphanol

(introduced by Decree of the Government of the Russian Federation dated June 30, 2010 N 486)

Vinylbital

Galazepam

Haloxazolam

Gammabutyrolactone (introduced by Decree of the Government of the Russian Federation of February 22, 2012 N 144)

Gammabutyrolactone

(introduced by Decree of the Government of the Russian Federation dated February 22, 2012 N 144)

Sodium 4-hydroxybutyrate and other hydroxybutyric acid salts

The position is excluded. — Decree of the Government of the Russian Federation of June 22, 2009 N 507

Dextromethorphan

Delorazepam

Kamazepam

Ketazolam

Clobazam

Cloxazolam

Clorazepate

Clotiazepam

Levamphetamine

Lefetamine

Loprazolam

Lormetazepam

Mazindol

Methylphenobarbital

Methylprilone

Mefenorex

Nalbuphine [(5-alpha, 6-alpha)-17-(cyclobutylmethyl)-4,5-epoxymorphinan-3,6,14-triol] (introduced by Decree of the Government of the Russian Federation of April 23, 2012 N 359)

The position is excluded. — Decree of the Government of the Russian Federation dated December 8, 2010 N 990

Nimetazepam

Nordazepam

Oxazolam

- hydroxybutyric acid

(introduced by Decree of the Government of the Russian Federation dated December 8, 2010 N 990)

The position is excluded. — Decree of the Government of the Russian Federation of June 30, 2010 N 486

Pinazepam

Pipradrol

Pyrovalerone

Prazepam

Secbutabarbital

Secobarbital

Tianeptine

(introduced by Decree of the Government of the Russian Federation dated June 30, 2010 N 486)

Phendimetrazine

Fencamfamin

Fenproporex

Fludiazepam

Cyclobarbital

Zipeprol

Ethyl loflazepate

Ethylamphetamine

Etinamat

Ethchlorovinol

Salts of substances listed in this list, if the existence of such salts is possible

<*>Including salts of the substances listed in the table, if the existence of such salts is possible, excluding salts of sulfuric, hydrochloric and acetic acids.

Notes 1. The classification of a substance as a corresponding narcotic drug, psychotropic substance or their precursor included in this list does not depend on what brand (trade) names, synonyms or abbreviations are used as its name. (clause 1 as amended by Decree of the Government of the Russian Federation dated 06/03/2010 N 398)

2. Control applies to preparations containing narcotic drugs and psychotropic substances specified in this list, regardless of their quantity and the presence of neutral components (water, starch, sugar, sodium bicarbonate, talc, etc.) (as amended by the Resolution Government of the Russian Federation dated June 3, 2010 N 398)

In relation to combination medicinal products containing, in addition to the main controlled substance, other pharmacologically active components, control is established on an individual basis by including this combined medicinal product in the appropriate list of this list.

3. A drug containing several precursors included in the tables of List IV of this list is controlled as the precursor it contains, provided for in the table of List IV of this list, which has the lowest serial number. (clause 3 as amended by Decree of the Government of the Russian Federation dated 06/03/2010 N 398)

5. The concentration of substances specified in List IV of this list is determined based on the mass fraction of the substance in the mixture (solution). (Clause 5 introduced by Decree of the Government of the Russian Federation dated 06/03/2010 N 398)

6. Derivatives of narcotic drugs and psychotropic substances are substances of synthetic or natural origin that are not included as independent items in the state register of medicines or in this list, the chemical structure of which is formed by the replacement (formal substitution) of one or more hydrogen atoms, halogens and (or) hydroxyl groups in the chemical structure of the corresponding narcotic drug or psychotropic substance into other monovalent and (or) divalent atoms or substituents (except for hydroxyl and carboxyl groups), the total number of carbon atoms in which should not exceed the number of carbon atoms in the original chemical structure of the corresponding narcotic drug or psychotropic substance.

If the same substance can be classified as a derivative of several narcotic drugs or psychotropic substances, it is recognized as a derivative of a narcotic drug or psychotropic substance, a change in the chemical structure of which requires the introduction of the smallest number of substituents and atoms. (Clause 6 introduced by Decree of the Government of the Russian Federation dated November 19, 2012 N 1178)

Substances and methods prohibited at all times

(out-of-competition and competitive periods)

Prohibited Substances

S1 - Androgens; Anabolic steroids and their analogues

S2 - Hormones of peptide structure; Growth factors and their analogues

S3 - Beta-2 agonists (β2-adrenergic agonists)

S4 - Hormones; Hormone antagonists; Metabolism modulators

S5 - Diuretics; Masking agents

Prohibited Methods

M1 - Manipulation of blood and its components

The following methods are prohibited:

1. Primary or repeated introduction of blood of autologous, allogeneic (homologous) or heterologous origin, or red blood cell preparations of any origin into the cardiovascular system.

2. Artificial improvement of the processes of oxygen consumption, transfer or delivery, including, but not limited to: the use of fluorinated derivatives, efaproxiral (RSR13) and modified hemoglobin-based drugs (for example, hemoglobin-based blood substitutes, microencapsulated hemoglobin), with the exception of the administration additional oxygen by inhalation.

3. Any form of intravascular manipulation of blood or its components by physical or chemical methods

M2 - Chemical and physical manipulations

The following methods are prohibited:

1. Falsification, as well as attempts to falsify samples taken as part of the doping control procedure in order to violate their integrity and authenticity. These manipulations include, but are not limited to: Actions to replace urine and/or change its properties in order to complicate analysis (for example, the introduction of protease enzymes).

M3 - Gene doping

The following are prohibited as they can improve athletic performance:

1. Transfer of nucleic acid polymers or nucleic acid analogues.

2. Use of gene editing agents aimed at changing the genomic sequence and/or transcriptional or epigenetic regulation of gene expression.

3. Use of normal or genetically modified cells.

Substances and methods prohibited during competition

S6 - Stimulants (Adrenergic agonists; Psychostimulants, etc.)

S7 - Drugs

S8 - Cannabinoids; Cannabimimetics

S9 - Glucocorticosteroids (GCS) - intramuscularly, intravenously, per os, per rectum

Substances prohibited in certain sports

P1 - Beta blockers

Unless otherwise noted, beta blockers are prohibited in-competition only in the following sports:

Motorsport (FIA)

Billiard sport (all disciplines) (WCBS)

Golf (IGF)

Darts (WDF)

Skiing/snowboarding (FIS)

Scuba diving (CMAS)

Shooting (ISSF, IPC) (also prohibited out-of-competition)

Archery (WA) (also prohibited out of competition).

Worldwide
anti-doping
agency

World Anti-Doping Code

INTERNATIONAL STANDARD

WORLD ANTI-DOPING CODE
PROHIBITED LIST 2009

The use of any drug should be limited to medical indications.

All Prohibited Substances are considered “Specified Substances” with the exception of substances listed in classes S1, S2, S4.4, S6.a and in the Prohibited Methods section in classes M1, M2 and M3.

SUBSTANCES AND METHODS PROHIBITED AT ALL TIMES
(BOTH IN-COMPETITION AND NON-COMPETITIVE PERIOD)

PROHIBITED SUBSTANCES

S1. ANABOLIC AGENTS

The use of anabolic agents is prohibited.

1. Anabolic androgenic steroids (AAS)

a) Exogenous* AAS, including

1-androstenediol (5α-androsta-1-ene-3β,17β-diol)
1-androstenedione (5α-androsta-1-ene-3,17-dione)
bolandiol (19-norandrostenediol)
bolasterone
boldenone
boldion (androsta-1,4-diene-3,17-dione)
gestrinone 4-hydroxytestosterone (4,17β-dihydroxy-androsta-4-en-3-one)
danazol (17α-ethynyl-17β-hydroxyandrosta-4-enoisoxazole)
dehydrochloromethyltestosterone (4-chloro-17β-hydroxy-17α-methylandrosta-1,4-dien-3-one)
deoxymethyltestosterone (17α-methyl-5α-androsta-2-en-17β-ol)
drostanolone
gestrinone 4hydroxytestosterone (4,17β-dihydroxyandrost-4-en-3-one);
calusterone
quinbolone
clostebol
mestanolone
mesterolone
Methandienone (17β-hydroxy-17α-methylandrosta-1,4-dien-3-one)
methandriol
methasterone (2α,17α-dimethyl-5α-androstane-3-one-17β-ol)
methenolone
Methyl-1-testosterone (17β-hydroxy-17α-methyl-5α-androsta-1-en-3-one)
methyldienolone (17β-hydroxy-17α-methylestra-4,9-dien-3-one)
methylnortestosterone (17β-hydroxy-17α-methylestra-4-en-3-one)
methyltestosterone
methyltrienolone (17β-hydroxy-17α-methylestra-4,9,11-trien-3-one)
mibolerone
19-norandrostenedione (estra-4-ene-3,17-dione)
nandrolone
norboleton
norclostebol
norethandrolone
oxabolone
oxandrolone
oxymesterone
oxymetholone
prostanozol (17β-hydroxy-5α-androstanopyrazole)
stanozolol
stenbolone
1-testosterone (17β-hydroxy-5α-androsta-1-en-3-one)
tetrahydrogestrinone (18α-homo-pregna-4,9,11-trien-17β-ol-3-one)
trenbolone
fluoxymesterone
formebolone
furazabol (17β-hydroxy-17α-methyl-5α-androsta-furazan)
quinbolone
ethylestrenol (19-nor-17α-pregna-4-en-17-ol)

b) Endogenous** AAS with exogenous administration:

androstenediol (androsta-5-ene-3β,17β-diol)
androstenedione (androsta-4-ene-3,17-dione)
dihydrotestosterone (17β-hydroxy-5α-androsta-3-one)
Prasterone (dihydroepiandrosterone, DHEA)
testosterone,

as well as the following metabolites and isomers:

4-androstenediol (androsta-4-ene-3β,17β-diol)
5α-androstane-3α,17α-diol
5α-androstane-3α,17β-diol
5α-androstane-3β,17α-diol
5α-androstane-3β,17β-diol
5-androstenedione (androsta-5-ene-3,17-dione)
androsta-4-ene-3α,17α-diol
androsta-4-ene-3α,17β-diol
androsta-4-ene-3β,17α-diol
androsta-5-ene-3α,17α-diol
androsta-5-ene-3α,17β-diol
androsta-5-ene-3β,17α-diol
3α-hydroxy-5α-androstan-17-one
3β-hydroxy-5α-androstan-17-one
19-norandrosterone
19-noretiocholanolone
epi-testosterone
epi-dihydrotestosterone

Comments for class S1.1b:

If any of the anabolic androgenic steroids can be produced endogenously (naturally), the Sample will be considered to contain a Prohibited Substance and the Analytical Finding will be Adverse if the concentration of the Prohibited Substance or its metabolites or markers and/or their respective ratios in the Athlete's Sample is outside the limits normal values ​​found in humans and corresponding to normal endogenous production by the body. In no event will a Sample be deemed to contain a Prohibited Substance if the Athlete demonstrates that the concentration of the Prohibited Substance or its metabolites or markers and/or their respective ratios in the Athlete's Sample may be caused by a pathological or physiological condition of the Athlete.

In all cases and at all concentrations, an Athlete's Sample will be considered to contain a Prohibited Substance and the laboratory will report an Adverse Analytical Finding if, based on any reliable method of analysis (e.g. IRMS - isotope ratio mass spectrometry), it can demonstrate that the Prohibited Substance has an exogenous origin. In such cases, no further investigation is carried out.

If the concentrations or ratios do not exceed normal values ​​for humans and reliable analytical methods (e.g., IRMS) do not reveal the exogenous origin of the substances, but there are significant data, such as comparison of endogenous steroid profiles, indicating the possible use of a prohibited substance, or the laboratory reports a ratio testosterone to epitestosterone (T/E) concentrations greater than four (4) to one (1), and reliable analytical methods (e.g., IRMS) have not demonstrated the exogenous origin of the substance, then further testing should be conducted by the Anti-Doping Organization by comparison with the results of previous testing or carrying out subsequent testing.

When further testing is necessary, the test result received from the laboratory is declared atypical rather than adverse. If the laboratory reports that additional reliable analytical methods (e.g., IRMS) indicate that the Prohibited Substance is of exogenous origin, then no further testing is required and the Sample will be considered to contain that Prohibited Substance. When additional reliable analytical methods (e.g., IRMS) have not been used and the results of at least three previous Tests are not known, further longitudinal profile studies of the Athlete through at least three surprise (no warning) Testing over the next three months must be conducted by the appropriate Anti-Doping Organization. . The result that caused this long-term study is declared atypical. If the athlete's profile determined through long-term studies is not physiologically normal, the result will be declared unfavorable.

In extremely rare individual cases, urine may contain endogenous boldenone in very low concentrations (several nanograms per milliliter (ng/ml)). If a laboratory reports such a case, and the use of any reliable analytical methods (eg, IRMS) does not reveal the exogenous origin of the substance, then further investigation may be carried out by performing additional tests.

If a laboratory reports the detection of 19-norandrosterone, the test result will be considered Adverse because the detection of this substance is scientifically valid evidence of the exogenous origin of the Prohibited Substance. In such cases, no further investigation is carried out.

If the Athlete refuses to cooperate during the investigation, the Athlete's Sample will be considered to contain a Prohibited Substance.

2. Other anabolic agents (the list is not exhaustive):

clenbuterol
selective androgen receptor modulators (SARMs)
tibolone
zeranol
zilpaterol

In this section:
*"exogenous" substances mean substances that cannot be produced by the body.
**"endogenous" substances mean substances that can be produced naturally by the body.

S2. HORMONES AND SIMILAR SUBSTANCES

The following substances and their releasing factors are prohibited:

1. Agents that stimulate the production of erythropoietin (erythropoiesis): Erythropoietin (EPO, EPO), darbepoetin (dEPO), hematid;
2. Growth hormone (hGH), insulin-like growth factors (eg, IGF-1), mechanical growth factors (MGFs);
3. Human chorionic gonadotropin (hCG) and luteinizing hormone (LH) are prohibited for men only;
4. Insulins;
5. Corticotropins;

and other substances with similar chemical structure or similar biological effects.

Comments for class S2:

Unless the Athlete demonstrates that the elevated concentration of a substance is due to his or her physiological or pathological condition, a Sample will be considered to contain any of the Prohibited Substances listed above if the concentrations of Prohibited Substances or their metabolites or markers and/or their respective ratios in the Athlete's Sample are outside the limits. normal values ​​that are found in humans and correspond to normal endogenous production by the body.

If the laboratory reports, based on a reliable analytical method, that the Prohibited Substance is of exogenous origin, the Sample will be considered to contain a Prohibited Substance and an Adverse Analytical Finding will be reported.

S3. BETA-2 AGONISTS

All beta-2 agonists, including their D- and L-isomers, are prohibited.

Thus, formoterol, salbutamol, salmeterol and terbutaline, when used by inhalation, require a therapeutic use exemption in accordance with the International Standard for Therapeutic Use Exemptions.

Regardless of whether a TUE has been granted, the presence of salbutamol in concentrations greater than 1000 ng/mL will be considered an Adverse Analytical Finding unless the Athlete can demonstrate through a controlled pharmacokinetic study that the finding is due to the use of therapeutic doses of salbutamol by inhalation.

S4. HORMONAL ANTAGONISTS AND MODULATORS

The following classes are prohibited:

1. Aromatase inhibitors, including but not limited to these substances: anastrozole, letrozole, aminoglutethimide, exemestane, formestane, testolactone.

2. Selective estrogen receptor modulators (SERMs), including, but not limited to: raloxifene, tamoxifen, toremifene.

3. Other antiestrogenic substances, including but not limited to: clomiphene, cyclophenyl, fulvestrant.

4. Agents that alter myostatin function, including, but not limited to, myostatin inhibitors.

S5. DIURETICS AND OTHER MASKING AGENTS

Masking agents are prohibited. These include:

Diuretics, probenecid, plasma volume expanders (eg, intravenous albumin, dextran, hydroxyethyl starch, and mannitol)
and other substances with similar biological effects.

Diuretics include:

amiloride
acetazolamide
bumetanide
indapamide
canrenone
metolazone
spironolactone
thiazides (eg bendroflumethiazide, chlorothiazide, hydrochlorothiazide) triamterene
furosemide
chlorthalidone
ethacrynic acid,

and other substances with similar chemical structures or similar biological effects with the exception of drosperinone and topical dorzolamine, which are not prohibited.

Comments for class S5:
A TUE will not be valid if the athlete's urine contains, in addition to a diuretic, a prohibited substance at a threshold or subthreshold concentration.

PROHIBITED METHODS

M1. ENHANCED OXYGEN TRANSFER

The following methods are prohibited:

1. Blood doping, including the use of blood of autologous, homologous or heterologous origin or red blood cells of any origin.

2. Artificially increasing oxygen consumption, transport, or delivery due to the use of perfluorates, efaproxiral (RSR13), or modified hemoglobin products (such as hemoglobin-based blood substitutes or microencapsulated hemoproducts), without limitation.

M2. CHEMICAL AND PHYSICAL MANIPULATIONS
1. Tampering or attempting to tamper with Samples collected during doping control in order to compromise their integrity and authenticity is prohibited. These manipulations include catheterization, urine change or changes in its properties, and are not limited to this list.

2. Intravenous infusions (infusions) are prohibited, except in cases of surgery, emergency medical care and clinical research.

MZ. GENE DOPING

The transfer of cells or genetically significant elements or the use of cells, genetically significant elements or pharmacological agents that modulate (change) the expression of genes capable of improving athletic performance is prohibited.

Peroxisome proliferator-activated receptor delta (PPARdelta) agonists, such as the GW 1516 type, and PPARdelta-AMP-activated protein kinase (AMPK) axis agonists, such as the FICAR type, are prohibited.

SUBSTANCES AND METHODS,
PROHIBITED DURING COMPETITIONS

In addition to the classes of substances listed in points S1-S5 and M1-M3, the following classes are prohibited during competition:
PROHIBITED SUBSTANCES

S6. STIMULANTS

All stimulants, including both optical isomers (D- and L-), if available, are prohibited. The exception is imidazole, used topically, as well as stimulants included in the Monitoring Program for 2009*.

Stimulants include:

a) stimulants that do not have any specific use:

adrafinil
amiphenazole
amfepramone
amphetamine
amphetaminyl
benzphetamine
benzylpiperazine
bromantane
dimethylamphetamine
clobenzorex
cocaine
cropropamide
crotetamide
mesocarb
methamphetamine (D-)
methylenedioxyamphetamine
methylenedioxymethamphetamine
p-methylamphetamine
mefenorex
mephentermine
modafinil
norfenfluramine
prolintane
famprofazone
phendimetrazine
4-phenylperacetam (carphedon, phenotropil)
fenetylline
fenkamin
phenmetrazine
fenproporex
phentermine
fenfluramine
furfenorex
ethylamphetamine

Stimulants not listed in this list are considered stimulants that have specific uses.

Translator's note: to explain which stimulants may have their own specific use, the 2008 Prohibited List included an explanation that was not included in the current version of the list: “The Prohibited List may contain special (specific) substances, the use of which may be considered unintended due to their general availability or the questionable nature of their ability to influence athletic performance.”

b) Stimulants with specific application:

adrenalin**
heptaminol
isometheptene
Katin***
levmethamphetamine
meclofenoxate
methylphenidate
methylephedrine****
niketamide
norphenephrine
oxylophrine
octopamine
parahydroxyamphetamine
pemoline
pentetrazole
propylhexedrine
selegilin
sibutramine
strychnine
tuaminoheptane
fenbutrazate
phencamphamine
phenpromethamine
etamivan
etilephrine
ephedrine****

* The Monitoring Program for 2009 includes the following substances that are not prohibited: bupropion, caffeine, phenylephrine, phenylpropanolamine, pipradol, pseudoephedrine, synephrine.

**Adrenaline contained in topical anesthetic or topical preparations (e.g., nasal or ophthalmic) is not considered a Prohibited Substance.

*** Katine is prohibited (the test is considered positive) if its content
in urine exceeds 5 micrograms per milliliter.

**** Ephedrine and methylephedrine are prohibited (the test is considered positive),
if the content of each of them in the urine exceeds 10 micrograms per milliliter.

S7. DRUGS

The following drugs are prohibited:

buprenorphine
hydromorphine
dextromoramide
diamorphine (heroin)
methadone
morphine
oxycodone
oxymorphone
pentazocine
pethidine
fentanyl and its derivatives.

S8. CANNABINOIDS

Cannabinoids, such as marijuana and hashish, are prohibited.

S9. GLUCOCORTICOSTEROIDS

The use of glucocorticosteroids is prohibited orally, rectally, intravenously or intramuscularly.

In accordance with the International Standard for Therapeutic Use Exemptions, a declaration for the use of glucocorticosteroids is drawn up by the Athlete for intra-articular, periarticular, intraligamentous, epidural and intradermal use and inhalation, with the exception of the methods below.

Local preparations applied to the skin (including iontophoresis and phonophoresis), gums, perianal area, as well as drops in the ears, nose and eyes are not prohibited, and their use does not require a declaration of use.

SUBSTANCES PROHIBITED IN CERTAIN SPORTS
P1. ALCOHOL

Alcohol (ethanol) is prohibited only during competitions in the sports listed below. It is determined by analyzing exhaled air and/or blood. A violation of the rules and a case of doping is considered to be exceeding the threshold concentration (blood content) of 0.10 g per liter.

Aeronautics (FAI)
Archery (FITA, IPC)
Motorsport (FIA)
Bowling (IPC bowls)

Karate (WKF)
Modern Pentathlon (UIPM)
for disciplines that include shooting
Motorsports (FIM)
Powerboating (UIM)

P2. BETA BLOCKERS

Unless specified, beta blockers are only prohibited in competition in the following sports:

Aeronautics (FAI)
Motorsport (FIA)
Billiard Sports (WCBS)
Bobsleigh (FIBT)
Wrestling (FILA)
Bowling (CMSB, IPC bowls)
Bowling nine- and ten-pin (FIQ)
Bridge (FMB)
Powerboating (UIM)
Gymnastics (FIG)
Curling (WCF)
Ski/snowboard (FIS) (ski jumping, freestyle, snowboard)
Motorsports (FIM)
Sailing (ISAF) (match racing only)
Modern Pentathlon (UIPM) for disciplines that include shooting
Archery (FITA, IPC) (permanently prohibited)
Shooting (ISSF, IPC) (prohibited at all times)

Beta blockers include (the list is not exhaustive):

alprenolol
atenolol
acebutolol
betaxolol
bisoprolol
bunolol
carvediol
carteolol
labetalol
levobunolol
metypranolol
metoprolol
pissed off
oxprenolol
pindolol
propanolol
sotalol
timolol
celiprolol
esmolol

Prohibited List 2009

Summary of key changes and clarifications

Introductory part
- Article 4.2.2 of the 2009 World Anti-Doping Code states the following: “All Prohibited Substances, other than substances in the class of anabolic agents and hormones and stimulant substances listed on the Prohibited List, will be considered “Specified” Substances for purposes of application of Article 10 (Sanctions). to athletes in individual sports). Prohibited Methods will not be treated as Specified Substances."
These changes are reflected in the Prohibited List by introducing the following phrase: “All Prohibited Substances are considered as “Specified Substances” with the exception of substances listed in classes S1, S2, S4.4, S6.a and in the Prohibited Methods section in classes M1, M2 and M3."

SUBSTANCES AND METHODS PROHIBITED AT ALL TIMES (BOTH IN-COMPETITION AND NON-COMPETITION)

S1. Anabolic agents
1- Anabolic androgenic steroids
- The nomenclature of prostanzol has been changed to 17β-hydroxy-5α-androsta pyrazole to best meet the requirements of the International Union of Fine and Applied Chemistry (IUPAC).
- Epitestosterone has been moved from section S5 (diuretics and other masking agents) to section S1 (anabolic agents and endogenous anabolic androgenic agents), since this substance is an isomer of testosterone. Thus, epitestosterone will retain its status as a non-specific substance when deciding on the imposition of sanctions.
- In accordance with the format of the World Anti-Doping Code, the classification of atypicality of endogenous AAS results has been transferred to the category of commentary.

S2. Hormones and similar substances
- To reflect the heterogeneity of new types of EPO-like substances in development, the term “erythropoietin” has been replaced by the phrase “erythropoiesis-stimulating agents.”
- HCG and LH are clearly labeled as gonadotropins, which are prohibited in men.
- The explanation at the end of this section has been converted into a commentary to reflect the format of the World Anti-Doping Code.

S3. Beta-2 agonists

- According to the new edition of the International Standard for Therapeutic Use Exemptions, a therapeutic use authorization is required for the use of inhaled forms of formaterol, salbutamol, salmeterol and terbutaline.
- If salbutamol is detected in a urine sample at a concentration exceeding 1000 ng/l, this fact will be classified as a negative test result until the athlete can demonstrate through a controlled pharmacokinetic study that the abnormal result is a consequence of the use of a therapeutic dose of inhaled forms of salbtamol. A controlled pharmacokinetic study should be performed in a hospital setting or a specialized medical center for the control of a given medical condition, where the prescribed dose can be clearly monitored and the analysis procedure is clearly documented.

S5. Diuretics and other masking agents
- As stated above, epitestosterone has been moved to section S1.
- Alpha reductase inhibitors are no longer classified as prohibited substances. A detailed study of steroid profiles has proven the ineffectiveness of their use as masking agents.

The phrase "intravenous administration" now precedes examples indicating agents that increase plasma volume - albumin, dextran, hydroxyethyl starch, to emphasize the fact that these substances are prohibited only when administered by the specified route; mannitol added as an example; the use of an inhaled form of mannitol is allowed, for example, when conducting a provocative test for asthma.

It has been stated that carbonic anhydrase inhibitors - dorsalomide and brinzolamide, when administered locally into the eyeball, are not prohibited. The logical explanation for this exception is that these drugs do not exhibit a diuretic effect when applied topically.

Prohibited Methods

M2. Chemical and physical manipulations
- Intravenous infusions are prohibited and therefore require a Therapeutic Use Exemption (TUE) except during surgery, emergency medical care or clinical examination. The purpose of this section is to prohibit the use of hemodilution, overhydration, and the administration of prohibited substances by intravenous infusion. Intravenous infusion is defined as the process of delivering fluids through a vein using a needle or similar device. The following are non-prohibited justified and medically permitted cases of intravenous infusions:

1.Emergencies, including resuscitation measures;
2. Blood transfusion resulting from blood loss;
3. Carrying out surgical interventions;
4. Administration of drugs and fluids when other routes of administration are not possible (for example, persistent vomiting) according to generally accepted medical practice, carrying out induced dehydration in special cases.
Performing injections using a regular syringe is not prohibited if the substance being injected is not prohibited and the volume of the injected drug does not exceed 50 ml.

M3. Gene doping
- The definition of “gene doping” has been changed to more fully reflect the technological capabilities in this area.
- Taking into account the latest scientific data, peroxime proliferator-activated receptor delta agonists and AMP activated protein kinase axis agonists have been added to the list.

Substances and methods prohibited during competitions

S6. Stimulants
- Taking into account Article 4.2.2 of the new edition of the Code, the List Streamlining Committee has identified all stimulants listed in the 2008 Prohibited List, transferring them to the categories of specific or non-specific. The facts were taken into account that there is a likelihood of applying for a therapeutic use permit and their pharmacological properties, which can improve athletic performance, cause harm to health, their widespread use in the form of components of commercially available drugs, legal availability on the market, illegal use, legal/controlled status, precedent and potential abuse in sports practice, transition to amphetamine and/or methamphetamine phase. All nonspecific stimulants are listed in section S6.a, while a list of examples of specific stimulants is included in section S6.b.
- Before a decision was made and pseudoephedrine was re-listed, it was determined that additional information and the initiation of scientific research to study the effect of this substance were required. Therefore, pseudoephedrine remains in the monitoring program.

S9. Glucocorticosteroids
- In accordance with the provisions of the 2009 Code, references to the abbreviated TI have been removed.
- In accordance with the International Standard for Therapeutic Use Exemptions, the athlete must complete a declaration on the use of glucocorticosteroids by intra-articular, periarticular, intraligamentous, epidural, intradermal and inhalation routes of administration.
- A TUE or declaration is not required for topical use of glucocorticosteroids.

Substances prohibited in certain sports

P1. Alcohol
- For all International Federations, the threshold doping value in blood and exhaled air has been harmonized, which is 0.1 g/liter.
- At the request of the International Bowling Federation (FIQ), nine-pin bowling is included. The WADA list ordering committee also included ten-pin bowling, as this discipline is represented by FIQ.

P2. Beta blockers
- At the request of the International Bowling Federation (FIQ), the name of nine-pin bowling has been corrected. The WADA List Organizing Committee also included ten-pin bowling in this category, since this discipline is represented by FIQ.
- At the request of the International Golf Federation, beta blockers are prohibited in the discipline of golf.

Special substances

This section is excluded, since in the new edition of the Code the definition of “special substances” has been changed. A distinction has been made between “Specified Substances” and “Prohibited Substances”, which are now included in the aqueous portion.

Monitoring program for 2009 *
The following substances were included in the monitoring program for 2009:
1. Stimulants, only during the competitive period: bupropion, caffeine, phenylephrine, phenylpropanolamine, pipradol, pseudoephedrine, synephrine.
2. Drugs, in-competition only: morphine/codeine combination.

*The World Anti-Doping Code (Article 4.5) states: “WADA, in consultation with Signatories and governments, shall establish a monitoring program for substances which are not on the Prohibited List but which WADA wishes to monitor for abuse in order to detect misuse in sport.”

Decree of the Government of the Russian Federation of June 30, 1998 N 681
"On approval of the list of narcotic drugs, psychotropic substances and their precursors subject to control in the Russian Federation"

With changes and additions from:

February 6, November 17, 2004, July 8, 2006, July 4, 2007, June 22, December 21, 31, 2009, April 21, 3, June 30, July 29, October 30, November 27, 8 December 2010, February 25, March 11, July 7, October 6, December 8, 2011, February 22, March 3, April 23, May 18, September 4, October 1, November 19, 23, 2012, 4 , February 26, June 13, July 10, September 9, November 7, December 16, 2013, March 22, May 31, June 23, October 25, December 9, 2014, February 27, April 9, May 8, 2 July, October 12, 2015, April 1, 2016, January 18, February 21, May 25, July 12, 29, 2017, June 22, 2018

ON APPROVAL OF THE LIST OF NARCOTIC DRUGS, PSYCHOTROPIC SUBSTANCES AND THEIR PRECURSORS SUBJECT TO CONTROL IN THE RUSSIAN FEDERATION

In accordance with the Federal Law “On Narcotic Drugs and Psychotropic Substances” (Collection of Legislation of the Russian Federation, 1998, No. 2, Art. 219), the Government of the Russian Federation decides:

Approve the attached list of narcotic drugs, psychotropic substances and their precursors subject to control in the Russian Federation.

Establish that changes and additions to the specified list are carried out on the proposal of the Ministry of Health of the Russian Federation jointly with the Ministry of Internal Affairs of the Russian Federation.

Chairman of the Government of the Russian Federation S. KIRIENKO
Approved by Decree of the Government of the Russian Federation of June 30, 1998 N 681

LIST OF DRUGS, PSYCHOTROPIC SUBSTANCES AND THEIR PRECURSORS SUBJECT TO CONTROL IN THE RUSSIAN FEDERATION

List of narcotic drugs and psychotropic substances, the circulation of which in the Russian Federation is prohibited in accordance with the legislation of the Russian Federation and international treaties of the Russian Federation (List I)

• Allylprodine
• Alfameprodine
• Alfamethadol
• Alpha-methylfentanyl
• Alpha-methylthiofentanyl
• Alfaprodine
• Alphacetylmethadol
• Anileridine
• Acetyl - alphamethylfentanyl
• Acetylhydrocodeine
• Acetylated opium
• Acetylcodeine
• Acetylmethadol
• Acetorphine
• BDB (L-(3,4-methylenedioxyphenyl)-2-butanamine)
• Bezitramide
• Benzetidine
• Benzylmorphine
• Beta-hydroxy-3-methylfentanyl
• Beta-hydroxyfentanyl
• Betameprodine
• Betamethadol
• Betaprodine
• Betacetylmethadol
• Hashish (anasha, cannabis resin)
• Heroin (diacetylmorphine)
• Hydrocodone
• Hydrocodone phosphate
• N-hydroxy-MDA
• Hydromorphinol
• Hydromorphone
• Desomorphine
• Diampromide
• Diacetylmorphine (heroin)
• Dihydromorphine
• Dimenoxadol
• N-Dimethylamphetamine
• Dimepheptanol
• Dimethylthiambutene
• Dioxafetyl butyrate
• Dipipanon
• Difenoxin
• Diethylthiambutene
• DMA (d, L-2,5-dimethoxy-alpha-methyl-phenyl-ethylamine)
• DMHP (dimethylheptylpyran)
• DMT (dimethyltryptamine)
• DOB (d, L-2,5-dimethoxy-4-bromo-amphetamine)
• DOX (d, L-2,5-dimethoxy-4-chloroamphetamine)
• DOET (d, L-2,5-dimethoxy-4-ethyl-amphetamine)
• Drotebanol
• DET (N,N-diethyltryptamine)
• Isomethadone
• Cannabis (marijuana)
• Ketobemidon
• Clonitazene
• Kodoxim
• Cocaine bush
• Homemade preparations from ephedrine or from preparations containing ephedrine
• Homemade preparations of pseudoephedrine or preparations containing pseudoephedrine
• Levomethorphan
• Levomoramide
• Levorphanol (Lemoran)
• Levophenacylmorphan
• Lysergic acid and its derivatives
• d-Lysergide (LSD, LSD-25)
• Coca leaf
• Poppy straw
• Cannabis oil (hashish oil)
• MBDB (N-Methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine)
• MDA (tenamphetamine)
• MDMA (d, L-3,4-methylenedioxy-N-alpha-dimethyl-phenyl-ethylamine)
• 3-Monoacetylmorphine
• 6-Monoacetylmorphine
• Mescaline
• Methadone
• d-Methadone
• L-Methadone
• Methadone intermediate (4-cyano-2-dimethylamino-4,4-diphenylbutane)
• Metazocin
• Methamphetamine
• Methyldesorphin
• Methyldihydromorphine
• 3-methylthiofentanyl
• 3-methylfentanyl
• N-methylephedrone
• Metopon
• Mirofin
• The milky juice of different types of poppy, which are not opium or oilseed poppy, but contain poppy alkaloids included in the lists of narcotic drugs and psychotropic substances
• MMDA (2-methoxy-alpha-4-methyl 4,5-(methylenedioxy)-phenethylamine)
• Moramide, intermediate (2-methyl-3-morpholine-1, 1-diphenylpropane-carboxylic acid)
• Morpheridine
• Morphine methyl bromide
• Morphine-N-oxide
• MPPP (1-methyl-4-phenyl-4-piperidinol propionate (ester))
• Nicodicodine
• Nicocodine
• Nicomorphine
• Horacimethadol
• Norcodeine
• Norlevorphanol
• Normethadone
• Normorphine
• Norpipanone
• Oxycodone (tecodin)
• Oxymorphone
• Opium (including medical) - coagulated juice of the opium or oil poppy
• Opium poppy (Papaver somniferum L)
• Oripavin
• Para - fluorofentanyl (para - fluorofentanyl)
• Parahexyl
• PEPAP (L-phenethyl-4-phenyl-4-piperidinol acetate (ester))
• Pethidine
• Pethidine intermediate A (4-cyano-1-methyl-4-phenylpiperidine)
• Piminodine
• Fruiting body (any part) of any type of mushroom containing psilocybin and/or psilocin
• PMA (4-methoxy-alpha-methylphenyl-ethylamine)
• Proheptazine
• Properidine
• Propiram
• Psilocybin
• Psilocin
• Racemethorphan
• Racemoramide
• Racemorphan
• Rolicyclidine
• 2C-B (4-bromo-2,5-dimethoxyphenethylamine)
• STP (DOM) (2-amino-1-(2,5-dimethoxy-4-methyl)phenylpropane)
• Tebacon
• Tenocyclidine
• Tetrahydrocannabinol (all isomers)
• Thiofentanil
• TMA (d, L-3,4,5-trimethoxy-alpha-methylphenyl-amine)
• Phenadoxone
• Fenadon
• Phenazocine
• Fenampromide
• Phenatine
• Phencyclidine
• Phenomorphan
• Phenoperidine
• Folkodin
• Furetidine
• Ecgonine, its esters and derivatives, which can be converted to ecgonine and cocaine
• Poppy straw extract (poppy straw concentrate)
• N-ETHYL-MDA (d, L-N-ethyl-alpha-methyl-3,4-(methylenedioxy) - phenethylamyl)
• Ethylmethylthiambutene
• Ethycyclidine
• Ethoxyridine
• Etonitazene
• Etorphine
• Etryptamine
• Ephedrone (methcathinone)

• Dexamphetamine
• Cathene (d-norpseudoephedrine)
• Cathinone (L-alpha-aminopropiophenone)
• Levamphetamine
• Meclocqualone
• Methaqualone
• 4-methylaminorex
• Methylphenidate (Ritalin)
• Isomers (if they are not specifically excluded) of narcotic drugs and psychotropic substances listed in this list, in cases where the existence of such isomers is possible within the framework of this chemical designation
• Esters and ethers of narcotic drugs and psychotropic substances listed in this list
• All mixtures containing narcotic drugs and psychotropic substances on this list, regardless of their quantity

List of narcotic drugs and psychotropic substances, the circulation of which is limited in the Russian Federation and in respect of which control measures are established in accordance with the legislation of the Russian Federation and international treaties of the Russian Federation (List II)

• p-Aminopropiophenone (PAPP) and its optical isomers (antidote against cyanide)
• Alfentanil
• Amphetamine (phenamine) and combination drugs containing phenamine (amphetamine)
• Buprenorphine
• Glutethimide (Hoxiron)
• Dextromoramide
• Dextropropoxyphene (ibuproxiron, proxivon, spasmoproxivon)
• Dihydrocodeine
• Diphenoxylate
• Codeine
• Codeine phosphate
• Cocaine
• Cocaine hydrochloride
• Codeine N-oxide
• Morphine
• Morphine hydrochloride
• Morphine sulfate
• Morphilong
• Omnopon
• Pentazocine
• Properidine
• Propiram
• Prosidol
• Piritramide (dipidolor)
• Reazek
• Tilidine suppositories in different dosages
• Sombrevin
• Sufentanil
• Alnagon tablets (codeine phosphate 20 mg, caffeine 80 mg, phenobarbital 20 mg, acetylsalicylic acid 20 mg)
• Tablets (codeine camphosulfonate 0.025 g, potassium sulfaguaiacol 0.100 g, thick grindelia extract 0.017 g)
• Codeine tablets 0.03 g + paracetamol 0.500 g
• Codeine phosphate tablets 0.015 g + sugar 0.25 g
• Codeine tablets 0.01 g, 0.015 g + sugar 0.25 g
• Codeine tablets 0.015 g + sodium bicarbonate 0.25 g
• Tablets "Codterpine" (codeine 0.015 g + sodium bicarbonate 0.25 g + terpinhydrate 0.25 g)
• Cough tablets. Ingredients: thermopsis herb powder - 0.01 g (0.02 g), codeine - 0.02 g (0.01 g), sodium bicarbonate - 0.2 g, licorice root powder - 0.2 g
• Thebaine
• Tilidin
• Trimeperidine (Promedol)
• Fentanyl
• Ethylmorphine
• Escodol
• Estocin
• Estocin hydrochloride
• Ethylmorphine hydrochloride

• Amobarbital (barbamyl)
• Amfepramone (fepranon, diethylpropion)
• Ketamine
• Ketamine hydrochloride (calypsol, ketalar)
• Tablets (barbamyl 0.15 g + brominated 0.15 g)
• Phenmetrazine
• Phentermine
• Sodium etaminal
• Halcion (triazolam)
• Salts of all narcotic drugs and psychotropic substances listed in this list, if the existence of such salts is possible

List of psychotropic substances, the circulation of which is limited in the Russian Federation and in respect of which certain control measures may be excluded in accordance with the legislation of the Russian Federation and international treaties of the Russian Federation (List III)

• Aminorex
• Aprofen
• Benzphetamine
• Halothane (fluorothane)
• Dextromethorphan
• Levamphetamine
• Lefetamine
• Mazindol
• Mefenorex
• Sodium hydroxybutyrate and other salts of hydroxybutyric acid
• Pentobarbital
• Pipradrol
• Taren
• Phendimetrazine
• Fenproporex
• Zipeprol
• Ethylamphetamine
• Salts of substances listed in this list, if the existence of such salts is possible

List of precursors, the circulation of which in the Russian Federation is limited and in respect of which control measures are established in accordance with the legislation of the Russian Federation and international treaties of the Russian Federation (List IV)

• Acetic anhydride
• Anthranilic acid
• N-acetylanthranilic acid
• Acetone
• Isosafrole
• Red phosphorus
• Lysergic acid (*)
• N-Methylephedrine (*)
• 3,4-Methylenedioxyphenyl-2-propanone
• Methyl ethyl ketone (2-butanone)
• Norpseudoephedrine (*)
• Potassium permanganate
• Piperopal
• Piperidine
• Pseudoephedrine (*)
• Safrole
• Sulfuric acid, excluding its salts
• Hydrochloric acid, excluding its salts
• Toluene
• Phenylacetic acid
• Phenylpropanolamine (*)
• 1-Phenyl-2-propanone
• Ergometrine (ergonovine) (*)
• Ergotamine (*)
• Ethyl ether
• Ephedrine (*)

Notes

1. Control applies to all products and substances specified in this list, no matter what brand names (synonyms) they are designated by.
2. Control also applies to preparations containing the agents and substances specified in this list, regardless of their quantity and the presence of neutral components (water, starch, sugar, sodium bicarbonate, talc, etc.). In relation to combination medicinal products containing, in addition to the main controlled substance, other pharmacologically active components, control is established on an individual basis by including this combined medicinal product in the appropriate list of this list.
3. Transit through the territory of the Russian Federation of narcotic drugs, psychotropic substances and their precursors included in this list is prohibited.